Profitelligence Profitelligence · Filing Ledger Open COR research →

Form 8-K · Current Report · Filed 2025-05-19

Cencora, Inc. Announces Underwriting Agreement for Senior Notes Issuance

On May 15, 2025, Cencora, Inc. entered into an Underwriting Agreement for the issuance and sale of €500,000,000 aggregate principal amount of its 2.875% Senior Notes due 2028 and €500,000,000 aggregate principal amount of its 3.625% Senior Notes due 2032. The offering is expected to close on May 22, 2025, and the net proceeds will be used for general corporate purposes.

Filer
Cencora Inc. COR · NYSE
Filed
Accession
0001104659-25-050462
CIK
0001140859
Signal
Medium impactHealthcare

Items reported

Item 8.01

Other Events

Convertible Notes Offering
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$290.22

Next session

+0.9%

Since filing

+7.3%

Latest close

$311.34

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from COR reporting the same item, with the next session's move:

Exhibits (1)

About Cencora Inc.

Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another COR filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts